Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 482
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT03777059 12-Week Placebo-controlled Study of Atogepant for the Preventive Treatm… |
Atogepant | Migraine | Phase 3 | COMPLETED | En attente / non publié | AbbVie | United States · Abington Neurological Associates, Wil… | 2018-12-14 → 2020-06-19 | Ouvrir |
| NCT03821584 PERCAM — Brain Perfusion Assessment in the Acute Phase of Migraine Aura |
PERCAM — Brain Perfusion Assessme… | Migraine | À vérifier | TERMINATED | En attente / non publié | Nantes University Hospital | France · CHU Nantes, Nantes, France | 2019-03-01 → 2021-07-22 | Ouvrir |
| NCT02795351 Induction of Migraine Aura With Sildenafil |
Sildenafil | Migraine | Phase 1 | COMPLETED | En attente / non publié | Herlev Hospital | Denmark · Department of Neurology, Herlev-Gentofte Ho… | 2015-06 → 2021-08 | Ouvrir |
| NCT05332431 Optical Coherence Tomography Findings in Migraine |
Optical coherence tomography (OCT) | Migraine | À vérifier | UNKNOWN | En attente / non publié | Medical University of Vienna | Non communiqué | 2022-04 → 2023-06-01 | Ouvrir |
| NCT05337254 A Study of the PK and Safety of Single Doses of STS101, DHE Injection a… |
Dihydroergotamine | Migraine | Phase 1 | COMPLETED | En attente / non publié | Satsuma Pharmaceuticals, Inc. | United States · Quotient Sciences Miami Inc., Miami, … | 2021-03-05 → 2021-06-04 | Ouvrir |
| NCT03939312 Extension Study to Evaluate the Long-Term Safety and Tolerability of Or… |
Atogepant | Migraine | Phase 3 | COMPLETED | En attente / non publié | AbbVie | United States · Abington Neurological Associates, Wil… | 2019-05-06 → 2021-03-31 | Ouvrir |
| NCT01924052 CGRP Induced Migraine Attacks in Patients With High and Low Genetic Load |
CGRP | Migraine | Non applicable | COMPLETED | En attente / non publié | Danish Headache Center | Non communiqué | 2013-06 → 2013-08 | Ouvrir |
| NCT05516251 Transcutaneous Supraorbital Nerve Stimulator Versus Topiramate in Preve… |
Transcutaneous Supraorbital Nerve… | Migraine | Non applicable | UNKNOWN | En attente / non publié | Tongji Hospital | China · Wensheng Qu, Wuhan, China | 2021-10-01 → 2023-09-30 | Ouvrir |
| NCT05281770 Monoclonal CGRP Antibodies for Migraine Prevention - a Nationwide Real … |
Erenumab | Migraine | À vérifier | UNKNOWN | En attente / non publié | Amgen | Austria · Clinic Hietzing, Vienna, Austria | Medical … | 2022-10-01 → 2025-12-01 | Ouvrir |
| NCT05617339 Tailored Digital Treatment for Migraine |
Tailored Digital Treatment for Mi… | Migraine | Non applicable | UNKNOWN | En attente / non publié | Vastra Gotaland Region | Sweden · FoU primary care Södra Älvsborg, Borås, Swed… | 2023-01-01 → 2025-12-31 | Ouvrir |
| NCT03235479 Safety and Efficacy Study in Adult Subjects With Acute Migraines |
Rimegepant | Migraine | Phase 3 | COMPLETED | En attente / non publié | University of South Florida | United States · Advanced Pharma CR, LLC, Miami, Unite… | 2017-07-18 → 2018-01-26 | Ouvrir |
| NCT03237845 Safety and Efficacy in Adult Subjects With Acute Migraines |
Rimegepant | Migraine | Phase 3 | COMPLETED | En attente / non publié | University of South Florida | United States · AGA Clinical Trials, Hialeah, United … | 2017-07-27 → 2018-01-31 | Ouvrir |
| NCT03266588 Open Label Safety Study in Acute Treatment of Migraine |
Rimegepant | Migraine | Phase 2/3 | COMPLETED | En attente / non publié | University of South Florida | United States · AGA Clinical Trials, Hialeah, United … | 2017-08-30 → 2019-07-15 | Ouvrir |
| NCT04968093 MINDKIDS — Mindfulness for Adolescents for CM and HFEM |
MINDKIDS — Mindfulness for Adoles… | Migraine | Non applicable | COMPLETED | En attente / non publié | Fondazione I.R.C.C.S. Istituto Ne… | Italy · Fondazione IRCCS Istituto Neurologico C. Best… | 2016-01 → 2021-01 | Ouvrir |
| NCT04905654 Migraine Inducing Effect of Levcromakalim in Patients With Migraine Wit… |
Levcromakalim | Migraine | Non applicable | COMPLETED | En attente / non publié | Danish Headache Center | Denmark · Danish Headache Center, Glostrup Municipali… | 2021-09-29 → 2023-05-16 | Ouvrir |
| NCT05454319 CER-MIG-1 — Cerebri Biofeedback Feasibility Trial |
Biofeedback | Migraine | Non applicable | COMPLETED | En attente / non publié | Nordic Brain Tech AS | Norway · St.Olavs Hospital HF, Trondheim, Norway | 2022-06-01 → 2022-09-27 | Ouvrir |
| NCT03009019 Efficacy, Tolerability, and Safety of DFN-15 |
DFN-15 Active | Migraine | Phase 3 | COMPLETED | En attente / non publié | BioDelivery Sciences International | United States · Site 601, West Palm Beach, United Sta… | 2016-12 → 2019-05 | Ouvrir |
| NCT03006276 Efficacy, Tolerability, and Safety Study of DFN-15 |
DFN-15 Active | Migraine | Phase 3 | COMPLETED | En attente / non publié | BioDelivery Sciences International | United States · Site 701, Oklahoma City, United State… | 2016-12 → 2019-05 | Ouvrir |
| NCT05742191 DST — The Effect of Daylight Saving Time Transitions on Sleep and Migra… |
DST — The Effect of Daylight Savi… | Migraine | À vérifier | UNKNOWN | En attente / non publié | OSF Healthcare System | United States · OSF HealthCare Saint Francis Medical … | 2023-02-06 → 2023-06-01 | Ouvrir |
| NCT05085483 Ketone for Migraine Prevention |
Ketone for Migraine Prevention | Migraine | Non applicable | COMPLETED | En attente / non publié | Société des Produits Nestlé (SPN) | Canada · Diex Research Sherbrooke Inc., Sherbrooke, C… | 2021-10-11 → 2022-11-28 | Ouvrir |
| NCT03963232 PERSIST — A Study of Galcanezumab (LY2951742) in Participants With Epis… |
Galcanezumab | Migraine | Phase 3 | COMPLETED | En attente / non publié | The Cleveland Clinic | China, India, Russia · Academician I.P. Pavlov First … | 2019-07-30 → 2022-03-11 | Ouvrir |
| NCT05891808 miR-155 Expression in Episodic and Chronic Migraine |
miR-155 Expression in Episodic an… | Migraine | À vérifier | UNKNOWN | En attente / non publié | IRCCS National Neurological Insti… | Italy · IRCCS Mondino Foundation, Pavia, Italy | 2020-09-22 → 2024-01-01 | Ouvrir |
| NCT04740827 ELEVATE — Atogepant for Prophylaxis of Migraine in Participants Who Fai… |
Atogepant 60 mg | Migraine | Phase 3 | COMPLETED | En attente / non publié | Fundación de Investigación Bioméd… | United States, Australia, Canada, Czechia, Denmark, F… | 2021-03-05 → 2022-08-04 | Ouvrir |
| NCT05449145 The Effects of Vitamin D Plus Omega-3 Polyunsaturated Fatty Acids in Pa… |
The Effects of Vitamin D Plus Ome… | Migraine | Non applicable | UNKNOWN | En attente / non publié | Kuang Tien General Hospital | Taiwan · Kuang Tien General Hospital, Taichung, Taiwan | 2022-05-01 → 2024-04-15 | Ouvrir |
| NCT03927144 Study of Sustained Benefit of AMG334 in Adult Episodic Migraine Patients |
AMG334 | Migraine | Phase 4 | COMPLETED | En attente / non publié | Amgen | United States, Argentina, Austria, Belgium, Czechia, … | 2019-05-15 → 2022-09-30 | Ouvrir |